Top Markets
Coin of the day
Upstream Bio, Inc. Upstream Bio, Inc.

Upstream Bio, Inc.

UPB
Peringkat dalam Saham #15300
Upstream Bio, Inc. is a biotechnology company in the clinical development... Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
Harga Saham
$6.64
Terakhir disinkronkan: 2026-08-31
Kapitalisasi Pasar
$361.08M
Perubahan (1 hari)
-0.82%
Perubahan (1 tahun)
-61.27%
Negara
US
Perdagangan Upstream Bio, Inc. (UPB)

Kategori

Riwayat hasil dividen untuk Upstream Bio, Inc. (UPB)
Hasil dividen (TTM) dari Upstream Bio, Inc. (simbol saham: UPB) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Upstream Bio, Inc. (UPB) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
0.00%
US
0.00%
NL
2.48%
AU
0.00%
US
0.00%
CH